Terug
23
Dagbereik
€ 220,53
€ 226,33
52-Weeksbereik
€ 204,90
€ 269,44
Volume
528.831
50D / 200D Gem.
€ 246,93
/
€ 245,43
Vorige Slotkoers
€ 221,73
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 35,7 | 0,3 |
| P/B | 3,3 | 3,0 |
| ROE % | 9,5 | 3,7 |
| Net Margin % | 11,3 | 3,8 |
| Rev Growth 5Y % | 15,1 | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Hold
€ 256,67
+14.9%
Low: € 245,00
High: € 265,00
Forward K/W
21,91
Forward WPA
€ 10,20
WPA Groei (sch.)
+0,0%
Omzet Sch.
5,94B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 12,26
€ 11,83 – € 12,48
|
6,74B | 5 |
| FY2027 |
€ 11,10
€ 10,85 – € 11,27
|
6,30B | 6 |
| FY2026 |
€ 10,20
€ 10,19 – € 10,24
|
5,94B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-04 | € 2,53 | € 2,53 | 0,0% |
| 2025-11-05 | € 2,35 | € 2,47 | +5,1% |
| 2025-08-06 | € 2,26 | € 2,34 | +3,5% |
| 2025-05-14 | € 2,60 | € 2,74 | +5,4% |
| 2025-02-05 | € 2,33 | € 2,32 | -0,4% |
| 2024-11-06 | € 2,12 | € 2,14 | +0,9% |
| 2024-08-06 | € 1,98 | € 2,03 | +2,5% |
| 2024-05-08 | € 2,35 | € 2,41 | +2,6% |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,36%
Growth (3Y)
10,06%
Growth (5Y)
9,28%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 17, 2026 | Mar 19, 2026 | € 0,63 | 1,00% |
| Nov 18, 2025 | Dec 18, 2025 | € 0,63 | 0,93% |
| Sep 04, 2025 | Sep 26, 2025 | € 0,63 | 0,96% |
| Jun 10, 2025 | Jun 26, 2025 | € 0,57 | 0,94% |
| Feb 20, 2025 | Mar 21, 2025 | € 0,57 | 1,01% |
| Nov 19, 2024 | Dec 19, 2024 | € 0,57 | 1,03% |
| Sep 05, 2024 | Sep 20, 2024 | € 0,57 | 0,89% |
| Jun 12, 2024 | Jun 26, 2024 | € 0,52 | 0,92% |
| Feb 22, 2024 | Mar 22, 2024 | € 0,52 | 0,86% |
| Nov 20, 2023 | Dec 21, 2023 | € 0,52 | 0,99% |
| Sep 05, 2023 | Sep 22, 2023 | € 0,52 | 0,86% |
| Jun 13, 2023 | Jun 28, 2023 | € 0,47 | 0,91% |
| Feb 23, 2023 | Mar 23, 2023 | € 0,47 | 0,98% |
| Nov 21, 2022 | Dec 16, 2022 | € 0,47 | 1,02% |
| Sep 06, 2022 | Sep 23, 2022 | € 0,47 | 0,89% |
| Jun 13, 2022 | Jun 28, 2022 | € 0,43 | 0,81% |
| Feb 24, 2022 | Mar 24, 2022 | € 0,43 | 0,74% |
| Nov 22, 2021 | Dec 17, 2021 | € 0,43 | 0,72% |
| Sep 02, 2021 | Sep 24, 2021 | € 0,43 | 0,75% |
| May 27, 2021 | Jun 25, 2021 | € 0,40 | 0,84% |
Belangrijkste Punten
Revenue grew 15,13% annually over 5 years — strong growth
Earnings grew 62,50% over the past year
Debt/Equity of 0,33 — conservative balance sheet
Generating 778,00M in free cash flow
P/E of 35,67 — premium valuation
PEG of 0,58 suggests growth is underpriced
Groei
Revenue Growth (5Y)
15,13%
Revenue (1Y)6,24%
Earnings (1Y)62,50%
FCF Growth (3Y)40,35%
Kwaliteit
Return on Equity
9,53%
ROIC7,38%
Net Margin11,26%
Op. Margin15,87%
Veiligheid
Debt / Equity
0,33
Current Ratio1,96
Interest Coverage10,05
Waardering
P/E Ratio
35,67
Forward P/E21,67
P/B Ratio3,32
EV/EBITDA27,64
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,24% | Revenue Growth (3Y) | 9,71% |
| Earnings Growth (1Y) | 62,50% | Earnings Growth (3Y) | 139,64% |
| Revenue Growth (5Y) | 15,13% | Earnings Growth (5Y) | 11,52% |
| Profitability | |||
| Revenue (TTM) | 5,46B | Net Income (TTM) | 614,64M |
| ROE | 9,53% | ROA | 6,06% |
| Gross Margin | 44,01% | Operating Margin | 15,87% |
| Net Margin | 11,26% | Free Cash Flow (TTM) | 778,00M |
| ROIC | 7,38% | FCF Growth (3Y) | 40,35% |
| Safety | |||
| Debt / Equity | 0,33 | Current Ratio | 1,96 |
| Interest Coverage | 10,05 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,36% |
| Dividend Growth (3Y) | 10,06% | Dividend Growth (5Y) | 9,28% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 35,67 | Forward P/E | 21,67 |
| P/B Ratio | 3,32 | P/S Ratio | 4,02 |
| PEG Ratio | 0,58 | Forward PEG | N/A |
| EV/EBITDA | 27,64 | Fwd EV/EBITDA | 15,12 |
| Forward P/S | 3,69 | Fwd Earnings Yield | 4,61% |
| FCF Yield | 3,55% | ||
| Market Cap | 21,92B | Enterprise Value | 23,95B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,46B | 5,14B | 4,54B | 4,22B | 3,11B |
| Net Income | 614,64M | 378,24M | 107,03M | 243,89M | 397,40M |
| EPS (Diluted) | 6,20 | 3,81 | 1,07 | 2,48 | 4,63 |
| Gross Profit | 2,40B | 2,22B | 1,98B | 1,88B | 1,34B |
| Operating Income | 866,64M | 836,12M | 791,10M | 477,82M | 548,37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 10,15B | 11,06B | 10,82B | 11,42B | 6,57B |
| Total Liabilities | 3,53B | 4,75B | 4,73B | 4,88B | 2,68B |
| Shareholders' Equity | 6,60B | 6,30B | 6,08B | 6,53B | 3,88B |
| Total Debt | 2,20B | 3,38B | 3,25B | 3,28B | 1,80B |
| Cash & Equivalents | 171,70M | 207,02M | 208,36M | 348,32M | 220,53M |
| Current Assets | 2,00B | 2,87B | 2,01B | 1,88B | 1,21B |
| Current Liabilities | 1,02B | 931,13M | 861,84M | 922,22M | 577,92M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#943 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026